Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Lipari Mining (N.LML) Announces Q1-2025 Production and Sales Results (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Harrow Inc HROW

Healthcare Biotechnology
Harrow, Inc. is an eyecare pharmaceutical company. The Company is engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the United States market. It provides a comprehensive portfolio of prescription and non-prescription pharmaceutical products. It owns commercial rights to portfolios of branded ophthalmic pharmaceutical products in North America... see more

Recent & Breaking News (NDAQ:HROW)

HARROW HEALTH INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Harrow Health To Contact Him Directly To Discuss Their Options

PR Newswire April 15, 2023

Harrow Health Shareholder Notice

Newsfile April 14, 2023

Harrow Health Shareholder Notice

Newsfile April 12, 2023

Harrow Health Shareholder Action Reminder

Newsfile April 10, 2023

HARROW HEALTH INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Harrow Health To Contact Him Directly To Discuss Their Options

PR Newswire April 8, 2023

Harrow Health Investor Alert

Newsfile April 7, 2023

Harrow Health Shareholder Notice

Newsfile April 5, 2023

Harrow Health Investor Alert

Newsfile April 3, 2023

HARROW HEALTH SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Harrow Health To Contact Him Directly To Discuss Their Options

PR Newswire April 1, 2023

Harrow Health Shareholder Action Reminder

Newsfile March 31, 2023

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Harrow Health, Inc. Investors to Inquire About Securities Class Action Investigation - HROW, HROWL, HROWM

PR Newswire March 30, 2023

Harrow Health Shareholder Action Reminder

Newsfile March 29, 2023

B. Riley Leads Financing to Support Harrow Health Acquisition

PR Newswire March 28, 2023

Harrow Announces New $100 Million Secured Credit Facility with Oaktree

Business Wire March 28, 2023

HARROW HEALTH INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Harrow Health To Contact Him Directly To Discuss Their Options

PR Newswire March 25, 2023

Harrow Health Shareholder Notice

Newsfile March 24, 2023

Harrow Announces Fourth Quarter and Year-End 2022 Financial Results

Business Wire March 23, 2023

Harrow Health Shareholder Action Reminder

Newsfile March 22, 2023

Harrow Health Shareholder Notice

Newsfile March 20, 2023

HARROW HEALTH SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Harrow Health To Contact Him Directly To Discuss Their Options

PR Newswire March 18, 2023